Search results for

Sure, kids have been playing with tops forever. But Beyblades are battling tops, and they come with their own fighting arena. They're a hit, and if you haven't been nagged for one this year, there's still time.

NPR's Scott Simon talks baseball with Howard Bryant of ESPN.com and ESPN the Magazine. This season's hot baseball teams are usually underdogs — the Cubs, Blue Jays and Mets.

In a year when hip-hop was frequently absent from the pop charts, NPR's music critic found that looking in darker corners revealed a genre that was flourishing.

NPR Music's Stephen Thompson reports on a handful of newcomers to the pop charts.

The economy still takes the top spot as the most pressing concern, but preserving democracy continues to rank high in NPR's polling, an aberration in American history.

In a wide-ranging and long interview, President-elect Donald Trump tells TIME Magazine his priorities for the first days of his second time at the presidency.

Mansour Dao, also Gadhafi's cousin, said toward the end, the despot was angry and still believed Libyans loved him.

Jacob remains the most popular name for boys born in the U.S., as it has been since 1999. Meanwhile, there's good news for fans of the King: Elvis is back in the top 1,000.

The recall involves some of the Japanese automaker's top-selling vehicles, including some model years for the RAV4 SUV, Corolla, Yaris and Matrix.

Xylazine, a veterinary anesthetic commonly referred to as “tranq,” has recently made its way into the illicit drug supply as a drug adulterant to enhance the effects of fentanyl, a potent opioid that can be lethal even in small amounts. The new drug combination has resulted in a 1,127% increase in xylazine-positive overdose mortalities in the American south from 2020 to 2021, and results in other problematic health effects including tissue necrosis. Now two researchers at the University of Kentucky will use a $2.65M grant to study how xylazine and fentanyl change the brain’s signaling pathways. This week Dr. Greg talks with Cassandra Gipson-Reichardt, associate professor in the University of Kentucky College of Medicine’s Department of Pharmacology and Nutritional Sciences, who is conducting the study with fellow professor Terry Hinds, Jr.